Posted on November 15, 2010 by Debra A. McCurdy

FDA Reopens Comment Periods on Generic Drug User Fee Program, PDUFA Reauthorization

This post was written by Paul Sheives.

FDA has extended its comment period its August 9, 2010 generic drug user fee program notice from October 17, 2010 to December 6, 2010.  FDA also has extended a comment period on reauthorization of the Prescription Drug User Fee Act (PDUFA) until October 21, 2011.

Tags: , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/230024
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.